Analytical chemistry is the scientific cornerstone of every successful botanical drug development program. The chemical complexity of botanical APIs — often containing hundreds of bioactive constituents — demands analytical expertise that goes far beyond standard pharmaceutical testing. At American Botanical Drug Corporation (ABDC), our botanical analytics services are purpose-built for the unique characterization, profiling, and regulatory compliance requirements of botanical drug substances and finished drug products.
Botanical Extraction & Isolation Engineering: Advanced process development for the precision isolation of both small and large molecules from botanical matrices, optimized simultaneously for yield, purity, and commercial scalability. Our extraction engineering expertise bridges the critical gap between laboratory-scale botanical drug substance development and industrial-scale GMP manufacturing.
Specialized Botanical Chromatographic Method Development: Engineering of sophisticated HPLC and LC-MS analytical methodologies specifically designed to resolve the complex, multi-constituent chemical profiles of botanical APIs and finished botanical drug products — the foundation of a defensible botanical drug IND submission.
Regulatory Analytical Testing for Botanical Drugs: Comprehensive analytical testing protocols designed to validate botanical API quality and demonstrate full compliance with FDA "Totality of Evidence" standards and applicable pharmacopeial requirements — a critical requirement for both botanical IND and NDA submissions.
Pharmaceutical Certification & Certificate of Analysis (CoA): Generation of rigorous, FDA-compliant Certificates of Analysis for botanical drug substances and finished drug products, documenting every Critical Quality Attribute (CQA) required for IND and NDA regulatory dossiers.
ICH-Compliant Botanical Stability Programs: Design and execution of stability-indicating analytical studies conducted in full accordance with ICH Q1A through Q1E guidelines, establishing the chemical and biological integrity of botanical drug formulations throughout their intended shelf life.
Chemical fingerprinting and botanical profiling are among the most technically demanding — and most FDA-scrutinized — aspects of botanical drug development. ABDC's botanical profiling capabilities are specifically engineered to meet the characterization depth required by FDA's Module 3 Quality requirements for botanical IND applications.
High-Resolution HPLC Botanical Profiling: Our specialized High-Performance Liquid Chromatography (HPLC) methodology is optimized to detect, resolve, and quantify low-abundance metabolites that are routinely masked in standard full-spectrum chromatograms. For botanical drug substances with complex chemical matrices, this level of analytical resolution is essential for meeting FDA botanical characterization expectations.
Deconvolution of Botanical Complexity: Leveraging an extensive proprietary database of historical chromatographic retention times and spectral reference data, ABDC achieves significantly higher success rates in structurally elucidating and identifying "unknown" peaks within botanical drug substance profiles — one of the most persistent analytical challenges in botanical drug development.
Regulatory Transformation of Unknown Peaks to Characterized Markers: Converting "unidentified peaks" into fully "characterized botanical markers" is a decisive step in satisfying FDA Module 3 Quality requirements for botanical IND applications. Demonstrating comprehensive control over the chemical composition of your botanical drug substance is not optional — it is a prerequisite for IND acceptance and a key determinant of FDA review outcomes. ABDC's botanical profiling expertise provides sponsors with the analytical evidence needed to meet this standard confidently.